These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4854342

  • 1. Some solubility studies of erythropoiesis regulatory factors (ERF)s.
    Lewis JP, Welch ET, Neal WA, DuBose CM, Lewis WG, Wright CS, Smith LL.
    Biochem Med; 1974 Aug; 10(4):374-86. PubMed ID: 4854342
    [No Abstract] [Full Text] [Related]

  • 2. The selective membrane filtration of an ESF-generating factor (EGF) in the presence of erythropoietin (ESF).
    Lewis JP, Welch ET, Neal WA, Moores RR, Lewis WG, Wright CS, DuBose CM, Smith LL.
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):322-4. PubMed ID: 5125532
    [No Abstract] [Full Text] [Related]

  • 3. The selective membrane filtration of an erythropoiesis-stimulating factor (ESF)--generating factor (EGF) in the presence of erythropoietin (ESF).
    Lewis JP, Welch ET, Neal WA, Moores RR, Lewis WG, Wright CS, DuBose CM, Smith LL.
    J Lab Clin Med; 1971 Nov; 78(5):845. PubMed ID: 5128896
    [No Abstract] [Full Text] [Related]

  • 4. Erythropoiesis and erythropoietin in multiple myeloma.
    Beguin Y.
    Leuk Lymphoma; 1995 Aug; 18(5-6):413-21. PubMed ID: 8528047
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of oral versus intraperitoneal administration of erythropoietin in stimulating erythropoiesis.
    Feleppa AE.
    Scand J Haematol; 1973 Aug; 10(3):186-8. PubMed ID: 4768685
    [No Abstract] [Full Text] [Related]

  • 6. The inactivation of erythropoietin with hydrolytic enzymes.
    Welch ET, Neal WA, Lewis JP, Dunn CD, Lange RD, Lutcher CL.
    Biochem Med; 1980 Jun; 23(3):272-81. PubMed ID: 7417234
    [No Abstract] [Full Text] [Related]

  • 7. Dialysis as a tool in the study of erythropoietin.
    Lewis JP, Alford DA, Moores RR, Gardner E, Wright CS, Smith LL, Scharnitzky WA, Neal WA.
    J Lab Clin Med; 1969 Jan; 73(1):154-62. PubMed ID: 4178411
    [No Abstract] [Full Text] [Related]

  • 8. Erythropoietin and its clinical promise.
    Erslev AJ, Schuster SJ, Caro J.
    Eur J Haematol; 1989 Nov; 43(5):367-73. PubMed ID: 2693128
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Erythopoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria.
    Hill A, Richards SJ, Rother RP, Hillmen P.
    Haematologica; 2007 Mar; 92(3):e31-3. PubMed ID: 17405753
    [Abstract] [Full Text] [Related]

  • 11. The glycogen phosphorylase of Tetrahymena pyriformis. I. Purification and characterization.
    Kahn V, Blum JJ.
    Arch Biochem Biophys; 1971 Mar; 143(1):80-91. PubMed ID: 5561751
    [No Abstract] [Full Text] [Related]

  • 12. [Erythropoiesis inhibitors in patients with aplastic anemia].
    Gudim VI, Moskaleva GP, Ivanova VS.
    Biull Eksp Biol Med; 1974 Jul; 78(7):28-30. PubMed ID: 4451707
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Erythropoietin treatment of anemia associated with multiple myeloma.
    Ludwig H, Fritz E, Kotzmann H, Höcker P, Gisslinger H, Barnas U.
    N Engl J Med; 1990 Jun 14; 322(24):1693-9. PubMed ID: 2342535
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Partial purification and some properties of thyroid peroxidase solubilized by alkaline treatment.
    Neary JT, Davidson B, Armstrong A, Maloof F.
    Prep Biochem; 1973 Jun 14; 3(5):495-508. PubMed ID: 4762653
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.